Sprinzl, Martin Franz; Puschnik, Andreas; Schlitter, Anna Melissa et al.
Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretionJOURNAL OF HEPATOLOGY. Bd. 62. H. 4. 2015 S. 863-870
Ettrich, T.; Perkofer, L.; Berger, A. W. et al.
Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIb trialEUROPEAN JOURNAL OF CANCER. Bd. 51. 2015 S. S457-S457
Diana, Tanja; Kanitz, Michael; Lehmann, Markus et al.
Standardization of a Bioassay for Thyrotropin Receptor Stimulating AutoantibodiesTHYROID. Bd. 25. H. 2. 2015 S. 169-175
Becker, Jessica; May, Andrea; Gerges, Christian et al.
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinomaCANCER MEDICINE. Bd. 4. H. 11. 2015 S. 1700-1704
Watzka, F. M.; Fottner, C.; Miederer, M. et al.
Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosisLANGENBECKS ARCHIVES OF SURGERY. Bd. 400. H. 3. 2015 S. 349-358
Watzka, F. M.; Fottner, C.; Miederer, M. et al.
Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis (vol 400, pg 349, 2015)LANGENBECKS ARCHIVES OF SURGERY. Bd. 400. H. 3. 2015 S. 359-359
Weinmann, Arndt; Koch, Sandra; Sprinzl, Martin et al.
Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patientsLIVER INTERNATIONAL. Bd. 35. H. 2. 2015 S. 591-600
Dargel, Christina; Bassani-Sternberg, Michal; Hasreiter, Julia et al.
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in MiceGASTROENTEROLOGY. Bd. 149. H. 4. 2015 S. 1042-1052
Farnik, Harald; Zimmermann, Tim; Herrmann, Eva et al.
Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantationLIVER INTERNATIONAL. Bd. 35. H. 1. 2015 S. 176-183
Maasberg, S.; Bacher, M.; Rinke, A. et al.
Temozolomid-Based Therapy in GEP- and Bronchopulmonary NEN from a Multicentric Study from GermanyNEUROENDOCRINOLOGY. Bd. 102. H. 1-2. 2015 S. 120-121